Diadexus Funding & Investors
Diadexus is a post-genomics company focused on translating raw genomics data into novel diagnostic and therapeutic products. The company develops these diagnostic and therapeutic products for improved detection, classification and prognosis of diseases.
diadexus.comTotal Amount Raised: $171,200,000
Diadexus Funding Rounds
Post Ipo Debt
$15,000,000
Post Ipo Debt Investors
Oxford FinancePost Ipo Debt
$4,500,000
Post Ipo Equity
$9,200,000
Post Ipo Equity Investors
Scale Venture PartnersBAKER BROS. ADVISORSAmerican International GroupPost Ipo Equity
$40,000,000
Post Ipo Equity Investors
Brookside CapitalBurrill & CompanyScale Venture PartnersRho Capital PartnersMosaix VenturesBAKER BROS. ADVISORSAmerican International GroupPost Ipo Equity
$102,500,000
Post Ipo Equity Investors
BA Venture Partners
Funding info provided by Diffbot.